☰

Berend Olivier - Publications

Affiliations: 
Psychopharmacology Utrecht University, Utrecht, Netherlands 
Area:
psychopharmacology
Website:
http://profs.library.uu.nl/index.php/profrec/getprofdata/1521/46/80/0
Tree Info Grants Similar researchers PubMed Report error

310 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Olivier JDA, Janssen JA, Esquivel-Franco DC, de Prêtre S, Olivier B. A new approach to 'on-demand' treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT receptor antagonist and SSRI in rats. Frontiers in Neuroscience. 17: 1224959. PMID 37781259 DOI: 10.3389/fnins.2023.1224959  0.369
2020 Esquivel-Franco DC, de Boer SF, Waldinger M, Olivier B, Olivier JDA. Pharmacological Studies on the Role of 5-HT Receptors in Male Sexual Behavior of Wildtype and Serotonin Transporter Knockout Rats. Frontiers in Behavioral Neuroscience. 14: 40. PMID 32296313 DOI: 10.3389/Fnbeh.2020.00040  0.442
2020 Gerritsen J, Bloemers J, van Rooij K, de Leede L, van der Geest R, Frijlink HW, Koppeschaar HPF, Olivier B, Tuiten A. The Effect of Food on the Pharmacokinetics of Buspirone After Single Administration of a Sublingual Testosterone and Oral Buspirone Combination Tablet in Healthy Female Subjects. Sexual Medicine. PMID 32088143 DOI: 10.1016/J.Esxm.2020.01.005  0.33
2020 Olivier JDA, Olivier B. Translational Studies in the Complex Role of Neurotransmitter Systems in Anxiety and Anxiety Disorders. Advances in Experimental Medicine and Biology. 1191: 121-140. PMID 32002926 DOI: 10.1007/978-981-32-9705-0_8  0.328
2020 Esquivel-Franco D, Wiegersma M, Janssen J, Colaprete C, Wesselink L, Olivier B, Olivier J. PS-3-9 Sexual Behavior in Male Serotonin Transporter Knockout Rats The Journal of Sexual Medicine. 17. DOI: 10.1016/J.Jsxm.2020.04.041  0.402
2019 Serefoglu EC, Olivier B, Janssen PKC, De Pretre S, Snoeren E. Preface for Marcel Waldinger special issue on premature ejaculation. International Journal of Impotence Research. PMID 31519978 DOI: 10.1038/S41443-019-0195-Y  0.68
2019 Bloemers J, Gerritsen J, van Rooij K, de Leede L, van der Geest R, Frijlink HW, Koppeschaar HPF, Olivier B, Tuiten A. The Effect of Food on the Pharmacokinetics of Sildenafil after Single Administration of a Sublingual Testosterone and Oral Sildenafil Combination Tablet in Healthy Female Subjects. The Journal of Sexual Medicine. 16: 1433-1443. PMID 31488289 DOI: 10.1016/J.Jsxm.2019.06.015  0.315
2019 Olivier JDA, Olivier B. Antidepressants and Sexual Dysfunctions: a Translational Perspective Current Sexual Health Reports. 11: 156-166. DOI: 10.1007/S11930-019-00205-Y  0.421
2018 Tuiten A, Michiels F, Böcker KB, Höhle D, van Honk J, de Lange RP, van Rooij K, Kessels R, Bloemers J, Gerritsen J, Janssen P, de Leede L, Meyer JJ, Everaerd W, Frijlink HW, ... ... Olivier B, et al. Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial. Women's Health (London, England). 14: 1745506518788970. PMID 30016917 DOI: 10.1177/1745506518788970  0.325
2018 Esquivel-Franco DC, Olivier B, Waldinger MD, Gutiérrez-Ospina G, Olivier JDA. Tramadol's Inhibitory Effects on Sexual Behavior: Pharmacological Studies in Serotonin Transporter Knockout Rats. Frontiers in Pharmacology. 9: 676. PMID 29997507 DOI: 10.3389/Fphar.2018.00676  0.451
2018 Franco DCE, Olivier B, Waldinger MD, Ospina GG, Olivier JDA. 215 Mechanisms underlying the sexual inhibitory effect of tramadol; a study in serotonin transporter knockout rats The Journal of Sexual Medicine. 15. DOI: 10.1016/J.Jsxm.2018.04.181  0.382
2017 Tuiten A, van Rooij K, Bloemers J, Eisenegger C, van Honk J, Kessels R, Kingsberg S, Derogatis LR, de Leede L, Gerritsen J, Koppeschaar HPF, Olivier B, Everaerd W, Frijlink HW, Höhle D, et al. Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials. The Journal of Sexual Medicine. PMID 29289554 DOI: 10.1016/J.Jsxm.2017.11.226  0.329
2017 Li Y, Pehrson AL, Oosting RS, Gulinello M, Olivier B, Sanchez C. A study of time- and sex-dependent effects of vortioxetine on rat sexual behavior: Possible roles of direct receptor modulation. Neuropharmacology. PMID 28414050 DOI: 10.1016/J.Neuropharm.2017.04.017  0.441
2017 Kops MS, Kjaer JB, Güntürkün O, Westphal KG, Korte-Bouws GA, Olivier B, Korte SM, Bolhuis JE. Brain monoamine levels and behaviour of young and adult chickens genetically selected on feather pecking. Behavioural Brain Research. 327: 11-20. PMID 28347825 DOI: 10.1016/J.Bbr.2017.03.024  0.358
2016 Olivier JD, Esquivel Franco DC, Oosting R, Waldinger M, Sarnyai Z, Olivier B. Tramadol: Effects on sexual behavior in male rats are mainly caused by its 5-HT reuptake blocking effects. Neuropharmacology. PMID 27890601 DOI: 10.1016/J.Neuropharm.2016.11.020  0.663
2016 Korte SM, Prins J, Van den Bergh FS, Oosting RS, Dupree R, Korte-Bouws GA, Westphal KG, Olivier B, Denys DA, Garland A, Güntürkün O. The 5-HT1A/1B-receptor agonist eltoprazine increases both catecholamine release in the prefrontal cortex and dopamine release in the nucleus accumbens and decreases motivation for reward and "waiting" impulsivity, but increases "stopping" impulsivity. European Journal of Pharmacology. PMID 27866999 DOI: 10.1016/J.Ejphar.2016.11.024  0.34
2016 Oosting RS, Chan JS, Olivier B, Banerjee P. Vilazodone does not inhibit sexual behavior in male rats in contrast to paroxetine: a role for 5-HT1A receptors? Neuropharmacology. PMID 27040795 DOI: 10.1016/J.Neuropharm.2016.03.045  0.447
2016 Oosting RS, Chan JS, Olivier B, Banerjee P, Choi YK, Tarazi F. Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats. Psychopharmacology. PMID 26758283 DOI: 10.1007/S00213-015-4198-1  0.441
2015 de Boer SF, Olivier B, Veening J, Koolhaas JM. The neurobiology of offensive aggression: revealing a modular view. Physiology & Behavior. PMID 26066717 DOI: 10.1016/J.Physbeh.2015.04.040  0.689
2015 van Rooij K, Poels S, Worst P, Bloemers J, Koppeschaar H, Goldstein A, Olivier B, Tuiten A. Efficacy of testosterone combined with a PDE5 inhibitor and testosterone combined with a serotonin (1A) receptor agonist in women with SSRI-induced sexual dysfunction. A preliminary study. European Journal of Pharmacology. 753: 246-51. PMID 25460030 DOI: 10.1016/J.Ejphar.2014.10.061  0.399
2015 Hendriksen H, Bink DI, Vergoossen DL, Suzet van Slobbe E, Olivier B, Oosting RS. Food restriction does not relieve PTSD-like anxiety. European Journal of Pharmacology. 753: 177-82. PMID 25460029 DOI: 10.1016/J.Ejphar.2014.10.060  0.316
2015 Olivier B. Serotonin: a never-ending story. European Journal of Pharmacology. 753: 2-18. PMID 25446560 DOI: 10.1016/J.Ejphar.2014.10.031  0.39
2015 Hendriksen H, Korte SM, Olivier B, Oosting RS. The olfactory bulbectomy model in mice and rat: one story or two tails? European Journal of Pharmacology. 753: 105-13. PMID 25446558 DOI: 10.1016/J.Ejphar.2014.10.033  0.357
2015 Kasahara M, Groenink L, Bijlsma EY, Olivier B, Sarnyai Z. Lifelong, central corticotropin-releasing factor (CRF) overexpression is associated with individual differences in cocaine-induced conditioned place preference. European Journal of Pharmacology. 753: 151-7. PMID 25094033 DOI: 10.1016/J.Ejphar.2014.07.050  0.584
2015 Veening JG, de Jong TR, Waldinger MD, Korte SM, Olivier B. The role of oxytocin in male and female reproductive behavior. European Journal of Pharmacology. 753: 209-28. PMID 25088178 DOI: 10.1016/J.Ejphar.2014.07.045  0.643
2015 Sarnyai Z, Jashar C, Olivier B. Modeling combined schizophrenia-related behavioral and metabolic phenotypes in rodents. Behavioural Brain Research. 276: 130-42. PMID 24747658 DOI: 10.1016/J.Bbr.2014.04.016  0.572
2014 Janssen PK, Schaik Rv, Olivier B, Waldinger MD. The 5-HT2C receptor gene Cys23Ser polymorphism influences the intravaginal ejaculation latency time in Dutch Caucasian men with lifelong premature ejaculation. Asian Journal of Andrology. 16: 607-10. PMID 24799636 DOI: 10.4103/1008-682X.126371  0.324
2014 Kops MS, Kjaer JB, Güntürkün O, Westphal KG, Korte-Bouws GA, Olivier B, Bolhuis JE, Korte SM. Serotonin release in the caudal nidopallium of adult laying hens genetically selected for high and low feather pecking behavior: an in vivo microdialysis study. Behavioural Brain Research. 268: 81-7. PMID 24720936 DOI: 10.1016/J.Bbr.2014.03.050  0.339
2014 Olivier B, Waldinger M. Guest editorial: pharmacology of female sexual behavior. Pharmacology, Biochemistry, and Behavior. 121: 1-2. PMID 24642115 DOI: 10.1016/J.Pbb.2014.03.007  0.371
2014 Poels S, Bloemers J, van Rooij K, Koppeschaar H, Olivier B, Tuiten A. Two novel combined drug treatments for women with hypoactive sexual desire disorder. Pharmacology, Biochemistry, and Behavior. 121: 71-9. PMID 24534417 DOI: 10.1016/J.Pbb.2014.02.002  0.34
2014 Janssen PK, van Schaik R, Zwinderman AH, Olivier B, Waldinger MD. The 5-HT₁A receptor C(1019)G polymorphism influences the intravaginal ejaculation latency time in Dutch Caucasian men with lifelong premature ejaculation. Pharmacology, Biochemistry, and Behavior. 121: 184-8. PMID 24440118 DOI: 10.1016/J.Pbb.2014.01.004  0.32
2014 Schijven D, Sousa VC, Roelofs J, Olivier B, Olivier JD. Serotonin 1A receptors and sexual behavior in a genetic model of depression. Pharmacology, Biochemistry, and Behavior. 121: 82-7. PMID 24345571 DOI: 10.1016/J.Pbb.2013.12.012  0.434
2014 de Theije CG, Wu J, Koelink PJ, Korte-Bouws GA, Borre Y, Kas MJ, Lopes da Silva S, Korte SM, Olivier B, Garssen J, Kraneveld AD. Autistic-like behavioural and neurochemical changes in a mouse model of food allergy. Behavioural Brain Research. 261: 265-74. PMID 24333575 DOI: 10.1016/J.Bbr.2013.12.008  0.306
2014 Bloemers J, Scholte HS, van Rooij K, Goldstein I, Gerritsen J, Olivier B, Tuiten A. Reduced gray matter volume and increased white matter fractional anisotropy in women with hypoactive sexual desire disorder. The Journal of Sexual Medicine. 11: 753-67. PMID 24298901 DOI: 10.1111/Jsm.12410  0.323
2014 Snoeren EM, Veening JG, Olivier B, Oosting RS. Serotonin 1A receptors and sexual behavior in female rats: a review. Pharmacology, Biochemistry, and Behavior. 121: 43-52. PMID 24275184 DOI: 10.1016/J.Pbb.2013.11.017  0.813
2014 Snoeren EM, Veening JG, Olivier B, Oosting RS. Serotonin 1A receptors and sexual behavior in male rats: a review. Pharmacology, Biochemistry, and Behavior. 121: 102-14. PMID 24239787 DOI: 10.1016/j.pbb.2013.11.007  0.811
2014 Douma TN, Millan MJ, Boulay D, Griebel G, Verdouw PM, Westphal KG, Olivier B, Groenink L. CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents. Psychopharmacology. 231: 1289-303. PMID 24186076 DOI: 10.1007/S00213-013-3315-2  0.328
2014 Bijlsma EY, Chan JS, Olivier B, Veening JG, Millan MJ, Waldinger MD, Oosting RS. Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release? Pharmacology, Biochemistry, and Behavior. 121: 88-101. PMID 24128918 DOI: 10.1016/J.Pbb.2013.10.004  0.665
2014 Oosting R, Chan J, Pehrson A, Li Y, Sanchez C, Olivier B. P.2.e.002 Vortioxetine's multimodal mechanism of action implies an absence of sexual side effects in a male rat model for sexual function European Neuropsychopharmacology. 24: S448. DOI: 10.1016/S0924-977X(14)70716-3  0.48
2014 Poels S, Bloemers J, van Rooij K, Koppeschaar H, Olivier B, Tuiten A. Een vernieuwende farmacotherapeutische behandeling voor vrouwen met hypoactive sexual desire disorder Neuropraxis. 18: 32-45. DOI: 10.1007/S12474-014-0038-Z  0.313
2014 Bijlsma E, Veening J, Oosting R, Waldinger MD, Olivier B. Rattenseks als model voor complex seksueel gedrag van mensen Neuropraxis. 18: 46-54. DOI: 10.1007/S12474-014-0037-0  0.554
2013 Kops MS, de Haas EN, Rodenburg TB, Ellen ED, Korte-Bouws GA, Olivier B, Güntürkün O, Korte SM, Bolhuis JE. Selection for low mortality in laying hens affects catecholamine levels in the arcopallium, a brain area involved in fear and motor regulation. Behavioural Brain Research. 257: 54-61. PMID 24076385 DOI: 10.1016/J.Bbr.2013.09.035  0.326
2013 Kops MS, de Haas EN, Rodenburg TB, Ellen ED, Korte-Bouws GA, Olivier B, Güntürkün O, Bolhuis JE, Korte SM. Effects of feather pecking phenotype (severe feather peckers, victims and non-peckers) on serotonergic and dopaminergic activity in four brain areas of laying hens (Gallus gallus domesticus). Physiology & Behavior. 120: 77-82. PMID 23911692 DOI: 10.1016/J.Physbeh.2013.07.007  0.361
2013 Olivier JD, Vinkers CH, Olivier B. The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders. Frontiers in Pharmacology. 4: 74. PMID 23781201 DOI: 10.3389/Fphar.2013.00074  0.305
2013 Veening JG, Olivier B. Intranasal administration of oxytocin: behavioral and clinical effects, a review. Neuroscience and Biobehavioral Reviews. 37: 1445-65. PMID 23648680 DOI: 10.1016/J.Neubiorev.2013.04.012  0.631
2013 van Heesch F, Prins J, Konsman JP, Westphal KG, Olivier B, Kraneveld AD, Korte SM. Lipopolysaccharide-induced anhedonia is abolished in male serotonin transporter knockout rats: an intracranial self-stimulation study. Brain, Behavior, and Immunity. 29: 98-103. PMID 23274951 DOI: 10.1016/J.Bbi.2012.12.013  0.304
2013 Bloemers J, van Rooij K, Poels S, Goldstein I, Everaerd W, Koppeschaar H, Chivers M, Gerritsen J, van Ham D, Olivier B, Tuiten A. Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder. The Journal of Sexual Medicine. 10: 791-809. PMID 23130782 DOI: 10.1111/J.1743-6109.2012.02984.X  0.379
2013 Poels S, Bloemers J, van Rooij K, Goldstein I, Gerritsen J, van Ham D, van Mameren F, Chivers M, Everaerd W, Koppeschaar H, Olivier B, Tuiten A. Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues. The Journal of Sexual Medicine. 10: 810-23. PMID 23130748 DOI: 10.1111/J.1743-6109.2012.02983.X  0.339
2013 van Rooij K, Poels S, Bloemers J, Goldstein I, Gerritsen J, van Ham D, van Mameren F, Chivers M, Everaerd W, Koppeschaar H, Olivier B, Tuiten A. Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms. The Journal of Sexual Medicine. 10: 824-37. PMID 23130675 DOI: 10.1111/J.1743-6109.2012.02982.X  0.377
2013 Oosting RS, Chan J, Olivier B, Banerjee P. P.1.g.028 Vilazodone exhibits a favorable sexual profile in male rats European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70315-8  0.347
2012 Pjetri E, de Haas R, de Jong S, Gelegen C, Oppelaar H, Verhagen LA, Eijkemans MJ, Adan RA, Olivier B, Kas MJ. Identifying predictors of activity based anorexia susceptibility in diverse genetic rodent populations. Plos One. 7: e50453. PMID 23226287 DOI: 10.1371/Journal.Pone.0050453  0.303
2012 Borre Y, Sir V, de Kivit S, Westphal KG, Olivier B, Oosting RS. Minocycline restores spatial but not fear memory in olfactory bulbectomized rats. European Journal of Pharmacology. 697: 59-64. PMID 23051675 DOI: 10.1016/J.Ejphar.2012.09.005  0.305
2012 Prins J, Kenny PJ, Doomernik I, Schreiber R, Olivier B, Mechiel Korte S. The triple reuptake inhibitor DOV 216,303 induces long-lasting enhancement of brain reward activity as measured by intracranial self-stimulation in rats. European Journal of Pharmacology. 693: 51-6. PMID 23010469 DOI: 10.1016/J.Ejphar.2012.07.047  0.331
2012 Vinkers CH, van Oorschot R, Nielsen EØ, Cook JM, Hansen HH, Groenink L, Olivier B, Mirza NR. GABA(A) receptor α subunits differentially contribute to diazepam tolerance after chronic treatment. Plos One. 7: e43054. PMID 22912786 DOI: 10.1371/Journal.Pone.0043054  0.303
2012 Hendriksen H, Bink DI, Daniels EG, Pandit R, Piriou C, Slieker R, Westphal KG, Olivier B, Oosting RS. Re-exposure and environmental enrichment reveal NPY-Y1 as a possible target for post-traumatic stress disorder. Neuropharmacology. 63: 733-42. PMID 22659471 DOI: 10.1016/J.Neuropharm.2012.05.028  0.324
2012 Vinkers CH, Olivier B. Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators? Advances in Pharmacological Sciences. 2012: 416864. PMID 22536226 DOI: 10.1155/2012/416864  0.312
2012 Herremans AH, Hijzen TH, Olivier B, Slangen JL. Serotonergic drug effects on a delayed conditional discrimination task in the rat; involvement of the 5-HT1A receptor in working memory. Journal of Psychopharmacology (Oxford, England). 9: 242-50. PMID 22297764 DOI: 10.1177/026988119500900307  0.38
2012 Borre Y, Bosman E, Lemstra S, Westphal KG, Olivier B, Oosting RS. Memantine partly rescues behavioral and cognitive deficits in an animal model of neurodegeneration. Neuropharmacology. 62: 2010-7. PMID 22248638 DOI: 10.1016/J.Neuropharm.2011.12.034  0.302
2012 Dekeyne A, Brocco M, Loiseau F, Gobert A, Rivet JM, Di Cara B, Cremers TI, Flik G, Fone KC, Watson DJ, Papp M, Sharp T, Serres F, Cespuglio R, Olivier B, et al. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization. The Journal of Pharmacology and Experimental Therapeutics. 340: 765-80. PMID 22178753 DOI: 10.1124/Jpet.111.187534  0.429
2012 Stoker AK, Olivier B, Markou A. Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal. Psychopharmacology. 221: 317-27. PMID 22147259 DOI: 10.1007/S00213-011-2578-8  0.327
2012 Pjetri E, Adan RA, Herzog H, de Haas R, Oppelaar H, Spierenburg HA, Olivier B, Kas MJ. NPY receptor subtype specification for behavioral adaptive strategies during limited food access. Genes, Brain, and Behavior. 11: 105-12. PMID 21923762 DOI: 10.1111/J.1601-183X.2011.00732.X  0.346
2012 Vinkers CH, Hendriksen H, van Oorschot R, Cook JM, Rallipalli S, Huang S, Millan MJ, Olivier B, Groenink L. Lifelong CRF overproduction is associated with altered gene expression and sensitivity of discrete GABA(A) and mGlu receptor subtypes. Psychopharmacology. 219: 897-908. PMID 21833506 DOI: 10.1007/S00213-011-2423-0  0.31
2012 Hendriksen H, Meulendijks D, Douma TN, Bink DI, Breuer ME, Westphal KG, Olivier B, Oosting RS. Environmental enrichment has antidepressant-like action without improving learning and memory deficits in olfactory bulbectomized rats. Neuropharmacology. 62: 270-7. PMID 21807004 DOI: 10.1016/J.Neuropharm.2011.07.018  0.331
2012 Borre Y, Jongbloets BC, Mendes JM, Olivier B, Oosting RS. P.2.017 Size does matter: environmental enrichment rescues cognitive and synaptic deficits following olfactory bulbectomy in mice European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70049-4  0.328
2011 Douma TN, Kolarz A, Postma Y, Olivier B, Groenink L. The amphetamine-chlordiazepoxide mixture, a pharmacological screen for mood stabilizers, does not enhance amphetamine-induced disruption of prepulse inhibition. Behavioural Brain Research. 225: 377-81. PMID 21820012 DOI: 10.1016/J.Bbr.2011.07.032  0.324
2011 Vinkers CH, Olivier B, Hanania T, Min W, Schreiber R, Hopkins SC, Campbell U, Paterson N. Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem. European Journal of Pharmacology. 668: 190-3. PMID 21762686 DOI: 10.1016/J.Ejphar.2011.06.054  0.333
2011 Vinkers CH, Groenink L, Pattij T, Olivier B, Bouwknecht JA. 5-HT(1A) receptor sensitivity in 5-HT(1B) receptor KO mice is unaffected by chronic fluvoxamine treatment. European Journal of Pharmacology. 667: 250-7. PMID 21723276 DOI: 10.1016/J.Ejphar.2011.06.018  0.648
2011 Kasahara M, Groenink L, Olivier B, Sarnyai Z. Corticotropin-releasing factor (CRF) over-expression down-regulates hippocampal dopamine receptor protein expression and CREB activation in mice. Neuro Endocrinology Letters. 32: 193-8. PMID 21552199  0.568
2011 Caldarone BJ, Wang D, Paterson NE, Manzano M, Fedolak A, Cavino K, Kwan M, Hanania T, Chellappan SK, Kozikowski AP, Olivier B, Picciotto MR, Ghavami A. Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380. Psychopharmacology. 217: 199-210. PMID 21487659 DOI: 10.1007/S00213-011-2271-Y  0.363
2011 Douma TN, Borre Y, Hendriksen H, Olivier B, Oosting RS. Simvastatin improves learning and memory in control but not in olfactory bulbectomized rats. Psychopharmacology. 216: 537-44. PMID 21384104 DOI: 10.1007/S00213-011-2245-0  0.339
2011 Olivier B, Chan JS, Snoeren EM, Olivier JD, Veening JG, Vinkers CH, Waldinger MD, Oosting RS. Differences in sexual behaviour in male and female rodents: role of serotonin. Current Topics in Behavioral Neurosciences. 8: 15-36. PMID 21374021 DOI: 10.1007/7854_2010_116  0.814
2011 Koolhaas JM, Bartolomucci A, Buwalda B, de Boer SF, Flügge G, Korte SM, Meerlo P, Murison R, Olivier B, Palanza P, Richter-Levin G, Sgoifo A, Steimer T, Stiedl O, van Dijk G, et al. Stress revisited: a critical evaluation of the stress concept. Neuroscience and Biobehavioral Reviews. 35: 1291-301. PMID 21316391 DOI: 10.1016/J.Neubiorev.2011.02.003  0.504
2011 Snoeren EM, Refsgaard LK, Waldinger MD, Olivier B, Oosting RS. Chronic paroxetine treatment does not affect sexual behavior in hormonally sub-primed female rats despite 5-HT₁(A) receptor desensitization. The Journal of Sexual Medicine. 8: 976-88. PMID 21269398 DOI: 10.1111/J.1743-6109.2010.02192.X  0.781
2011 Snoeren EM, Bovens A, Refsgaard LK, Westphal KG, Waldinger MD, Olivier B, Oosting RS. Combination of testosterone and vardenafil increases female sexual functioning in sub-primed rats. The Journal of Sexual Medicine. 8: 989-1001. PMID 21235726 DOI: 10.1111/J.1743-6109.2010.02177.X  0.756
2011 Kasahara M, Groenink L, Kas MJ, Bijlsma EY, Olivier B, Sarnyai Z. Influence of transgenic corticotropin-releasing factor (CRF) over-expression on social recognition memory in mice. Behavioural Brain Research. 218: 357-62. PMID 21192987 DOI: 10.1016/J.Bbr.2010.12.029  0.557
2011 Bijlsma EY, van Leeuwen ML, Westphal KG, Olivier B, Groenink L. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex. Neuroscience. 173: 82-92. PMID 21093544 DOI: 10.1016/J.Neuroscience.2010.11.026  0.351
2011 Prins J, Westphal KG, Korte-Bouws GA, Quinton MS, Schreiber R, Olivier B, Korte SM. The potential and limitations of DOV 216,303 as a triple reuptake inhibitor for the treatment of major depression: a microdialysis study in olfactory bulbectomized rats. Pharmacology, Biochemistry, and Behavior. 97: 444-52. PMID 20934452 DOI: 10.1016/J.Pbb.2010.10.001  0.348
2011 Houtepen LC, Peterse DP, Westphal KG, Olivier B, Vinkers CH. The autonomic stress-induced hyperthermia response is not enhanced by several anxiogenic drugs. Physiology & Behavior. 102: 105-9. PMID 20828578 DOI: 10.1016/J.Physbeh.2010.09.002  0.365
2011 Groenink L, Bijlsma EY, van Bogaert MJ, Oosting RS, Olivier B. Serotonin1A receptor deletion does not interact with maternal separation-induced increases in startle reactivity and prepulse inhibition deficits. Psychopharmacology. 214: 353-65. PMID 20811879 DOI: 10.1007/S00213-010-1998-1  0.331
2011 Snoeren EM, Chan JS, de Jong TR, Waldinger MD, Olivier B, Oosting RS. A new female rat animal model for hypoactive sexual desire disorder; behavioral and pharmacological evidence. The Journal of Sexual Medicine. 8: 44-56. PMID 20807327 DOI: 10.1111/J.1743-6109.2010.01998.X  0.761
2011 Chan JS, Snoeren EM, Cuppen E, Waldinger MD, Olivier B, Oosting RS. The serotonin transporter plays an important role in male sexual behavior: a study in serotonin transporter knockout rats. The Journal of Sexual Medicine. 8: 97-108. PMID 20704641 DOI: 10.1111/J.1743-6109.2010.01961.X  0.781
2011 Vinkers CH, Mirza N, Olivier B. P.2.015 The contribution of GABAA receptor alpha subunits in the actions of benzodiazepines using stress-induced hyperthermia in rats European Neuropsychopharmacology. 21. DOI: 10.1016/S0924-977X(11)70054-2  0.312
2010 Chan JS, Waldinger MD, Olivier B, Oosting RS. Drug-induced sexual dysfunction in rats. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 9.34. PMID 20938926 DOI: 10.1002/0471142301.Ns0934S53  0.373
2010 Caldarone BJ, Paterson NE, Zhou J, Brunner D, Kozikowski AP, Westphal KG, Korte-Bouws GA, Prins J, Korte SM, Olivier B, Ghavami A. The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties. The Journal of Pharmacology and Experimental Therapeutics. 335: 762-70. PMID 20864506 DOI: 10.1124/Jpet.110.174011  0.346
2010 Hendriksen H, Prins J, Olivier B, Oosting RS. Environmental enrichment induces behavioral recovery and enhanced hippocampal cell proliferation in an antidepressant-resistant animal model for PTSD. Plos One. 5: e11943. PMID 20700523 DOI: 10.1371/Journal.Pone.0011943  0.346
2010 Vinkers CH, van Oorschot R, Korte SM, Olivier B, Groenink L. 5-HT1A receptor blockade reverses GABA(A) receptor alpha3 subunit-mediated anxiolytic effects on stress-induced hyperthermia. Psychopharmacology. 211: 123-30. PMID 20535452 DOI: 10.1007/S00213-010-1895-7  0.341
2010 Millan MJ, Dekeyne A, Gobert A, Mannoury la Cour C, Brocco M, Rivet JM, Di Cara B, Lejeune F, Cremers TI, Flik G, de Jong TR, Olivier B, de Nanteuil G. S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetine. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 599-621. PMID 20483567 DOI: 10.1016/J.Euroneuro.2010.04.003  0.392
2010 Snoeren E, Chan J, Bovens A, Cuppen E, Waldinger M, Olivier B, Oosting R. Serotonin transporter null mutation and sexual behavior in female rats: 5-HT1A receptor desensitization. The Journal of Sexual Medicine. 7: 2424-34. PMID 20456632 DOI: 10.1111/J.1743-6109.2010.01829.X  0.769
2010 Bijlsma EY, de Jongh R, Olivier B, Groenink L. Fear-potentiated startle, but not light-enhanced startle, is enhanced by anxiogenic drugs. Pharmacology, Biochemistry, and Behavior. 96: 24-31. PMID 20394767 DOI: 10.1016/J.Pbb.2010.04.002  0.364
2010 Paterson NE, Fedolak A, Olivier B, Hanania T, Ghavami A, Caldarone B. Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents. Pharmacology, Biochemistry, and Behavior. 95: 449-56. PMID 20346966 DOI: 10.1016/J.Pbb.2010.03.006  0.318
2010 Prins J, Denys DA, Westphal KG, Korte-Bouws GA, Quinton MS, Schreiber R, Groenink L, Olivier B, Korte SM. The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats. European Journal of Pharmacology. 633: 55-61. PMID 20153745 DOI: 10.1016/J.Ejphar.2010.02.009  0.351
2010 Vinkers CH, Bijlsma EY, Houtepen LC, Westphal KG, Veening JG, Groenink L, Olivier B. Medial amygdala lesions differentially influence stress responsivity and sensorimotor gating in rats. Physiology & Behavior. 99: 395-401. PMID 20006965 DOI: 10.1016/J.Physbeh.2009.12.006  0.621
2010 Olivier JD, Cools AR, Deen PM, Olivier B, Ellenbroek BA. Blockade of dopamine, but not noradrenaline, transporters produces hyperthermia in rats that lack serotonin transporters. European Journal of Pharmacology. 629: 7-11. PMID 20004658 DOI: 10.1016/J.Ejphar.2009.11.049  0.348
2010 Vinkers CH, Oosting RS, van Bogaert MJ, Olivier B, Groenink L. Early-life blockade of 5-HT(1A) receptors alters adult anxiety behavior and benzodiazepine sensitivity. Biological Psychiatry. 67: 309-16. PMID 19811773 DOI: 10.1016/J.Biopsych.2009.08.013  0.373
2010 Vinkers CH, Olivier B, Bouwknecht JA, Groenink L, Olivier J. Stress-Induced Hyperthermia, the Serotonin System and Anxiety The Open Pharmacology Journal. 4. DOI: 10.2174/1874143601004010015  0.396
2010 Vinkers CH, Cryan JF, Olivier B, Groenink L. Elucidating GABAA and GABAB receptor functions in anxiety using the stress-induced hyperthermia paradigm: A review Open Pharmacology Journal. 4: 1-14. DOI: 10.2174/1874143601004010001  0.356
2009 Veening JG, Böcker KB, Verdouw PM, Olivier B, De Jongh R, Groenink L. Activation of the septohippocampal system differentiates anxiety from fear in startle paradigms. Neuroscience. 163: 1046-60. PMID 19580851 DOI: 10.1016/J.Neuroscience.2009.06.064  0.608
2009 Breuer ME, Groenink L, Oosting RS, Buerger E, Korte M, Ferger B, Olivier B. Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats. European Journal of Pharmacology. 616: 134-40. PMID 19549514 DOI: 10.1016/J.Ejphar.2009.06.029  0.355
2009 Vinkers CH, de Jong NM, Kalkman CJ, Westphal KG, van Oorschot R, Olivier B, Korte SM, Groenink L. Stress-induced hyperthermia is reduced by rapid-acting anxiolytic drugs independent of injection stress in rats. Pharmacology, Biochemistry, and Behavior. 93: 413-8. PMID 19520106 DOI: 10.1016/J.Pbb.2009.05.017  0.304
2009 Paterson NE, Malekiani SA, Foreman MM, Olivier B, Hanania T. Pharmacological characterization of harmaline-induced tremor activity in mice. European Journal of Pharmacology. 616: 73-80. PMID 19497322 DOI: 10.1016/J.Ejphar.2009.05.031  0.326
2009 Gerritsen J, van der Made F, Bloemers J, van Ham D, Kleiverda G, Everaerd W, Olivier B, Levin R, Tuiten A. The clitoral photoplethysmograph: a new way of assessing genital arousal in women. The Journal of Sexual Medicine. 6: 1678-87. PMID 19473468 DOI: 10.1111/J.1743-6109.2009.01228.X  0.33
2009 Vinkers CH, Groenink L, van Bogaert MJ, Westphal KG, Kalkman CJ, van Oorschot R, Oosting RS, Olivier B, Korte SM. Stress-induced hyperthermia and infection-induced fever: two of a kind? Physiology & Behavior. 98: 37-43. PMID 19375439 DOI: 10.1016/J.Physbeh.2009.04.004  0.323
2009 Chan JS, Kim DJ, Ahn CH, Oosting RS, Olivier B. Clavulanic acid stimulates sexual behaviour in male rats. European Journal of Pharmacology. 609: 69-73. PMID 19285063 DOI: 10.1016/J.Ejphar.2009.03.009  0.369
2009 van der Made F, Bloemers J, Yassem WE, Kleiverda G, Everaerd W, van Ham D, Olivier B, Koppeschaar H, Tuiten A. The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction. The Journal of Sexual Medicine. 6: 777-90. PMID 19207276 DOI: 10.1111/J.1743-6109.2008.01142.X  0.339
2009 van der Made F, Bloemers J, van Ham D, El Yassem W, Kleiverda G, Everaerd W, Olivier B, Tuiten A. Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without vardenafil on physiological sexual arousal in women with sexual dysfunction: a pilot study. The Journal of Sexual Medicine. 6: 429-39. PMID 19138366 DOI: 10.1111/J.1743-6109.2008.01103.X  0.339
2009 Vinkers CH, Breuer ME, Westphal KG, Korte SM, Oosting RS, Olivier B, Groenink L. Olfactory bulbectomy induces rapid and stable changes in basal and stress-induced locomotor activity, heart rate and body temperature responses in the home cage. Neuroscience. 159: 39-46. PMID 19136045 DOI: 10.1016/J.Neuroscience.2008.12.009  0.32
2009 Breuer ME, van Gaalen MM, Wernet W, Claessens SE, Oosting RS, Behl B, Korte SM, Schoemaker H, Gross G, Olivier B, Groenink L. SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model. Naunyn-Schmiedeberg's Archives of Pharmacology. 379: 101-6. PMID 18668225 DOI: 10.1007/S00210-008-0336-1  0.38
2009 Broceo M, Gobert A, Cour CMl, Dekeyne A, Nanteuil GD, Olivier B, Jong TRD, Cremers TI, Flick G, Millan MJ. P.2.d.004 S41744, a dual NK1 antagonist/5-HT reuptake inhibitor and antidepressant: a comparison to aprepitant and paroxetine European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70670-4  0.31
2009 Snoeren E, Chan JSW, Cuppen E, Olivier B, Oosting RS. P.2.23 5-HT1A receptor desensitization as mechanism underlying the lack of sexual dysfunction in female serotonin transporter knockout rats European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70061-6  0.763
2008 Groenink L, Verdouw PM, van Oorschot R, Olivier B. Models of anxiety: ultrasonic vocalizations of isolated rat pups. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit 5.18. PMID 22294223 DOI: 10.1002/0471141755.Ph0518S43  0.359
2008 Breuer ME, Chan JS, Oosting RS, Groenink L, Korte SM, Campbell U, Schreiber R, Hanania T, Snoeren EM, Waldinger M, Olivier B. The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 908-16. PMID 18789657 DOI: 10.1016/J.Euroneuro.2008.07.011  0.762
2008 Kas MJ, de Mooij-van Malsen AJ, Olivier B, Spruijt BM, van Ree JM. Differential genetic regulation of motor activity and anxiety-related behaviors in mice using an automated home cage task. Behavioral Neuroscience. 122: 769-76. PMID 18729629 DOI: 10.1037/0735-7044.122.4.769  0.319
2008 Brocco M, Dekeyne A, Mannoury la Cour C, Touzard M, Girardon S, Veiga S, de Nanteuil G, deJong TR, Olivier B, Millan MJ. Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 729-50. PMID 18657401 DOI: 10.1016/J.Euroneuro.2008.06.002  0.357
2008 Olivier JD, Cools AR, Olivier B, Homberg JR, Cuppen E, Ellenbroek BA. Stress-induced hyperthermia and basal body temperature are mediated by different 5-HT(1A) receptor populations: a study in SERT knockout rats. European Journal of Pharmacology. 590: 190-7. PMID 18606402 DOI: 10.1016/J.Ejphar.2008.06.008  0.408
2008 Chan JS, Olivier B, de Jong TR, Snoeren EM, Kooijman E, van Hasselt FN, Limpens JH, Kas MJ, Waldinger MD, Oosting RS. Translational research into sexual disorders: pharmacology and genomics. European Journal of Pharmacology. 585: 426-35. PMID 18423444 DOI: 10.1016/J.Ejphar.2008.02.098  0.76
2008 Vinkers CH, van Bogaert MJ, Klanker M, Korte SM, Oosting R, Hanania T, Hopkins SC, Olivier B, Groenink L. Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (SIH) paradigm. European Journal of Pharmacology. 585: 407-25. PMID 18420191 DOI: 10.1016/J.Ejphar.2008.02.097  0.335
2008 Groenink L, Dirks A, Verdouw PM, de Graaff M, Peeters BW, Millan MJ, Olivier B. CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF. Biological Psychiatry. 63: 360-8. PMID 17716630 DOI: 10.1016/J.Biopsych.2007.06.002  0.358
2008 Derijks HJ, Heerdink ER, Janknegt R, Koning FHD, Olivier B, Loonen AJ, Egberts AC. Visualizing Pharmacological Activities of Antidepressants: A Novel Approach The Open Pharmacology Journal. 2: 54-62. DOI: 10.2174/1874143600802010054  0.341
2008 de Mooij-van Malsen J, Olivier B, Herzhog H, Kas M. P.2.15 Behavioural changes in NPY-Y2 and 5HT-1a receptor deficient mice in an automated home cage task for avoidance behaviour European Neuropsychopharmacology. 18: s48-s49. DOI: 10.1016/S0924-977X(08)70056-7  0.357
2008 Chan J, Oosting RS, Kooijman E, Hasselt FNv, Snoeren EMS, Waldinger MD, Olivier B. P.2.13 Translational research into sexual disorders: pharmacology and behavior European Neuropsychopharmacology. 18. DOI: 10.1016/S0924-977X(08)70054-3  0.326
2007 Olivier JD, de Jong TR, Jos Dederen P, van Oorschot R, Heeren D, Pattij T, Waldinger MD, Coolen LM, Cools AR, Olivier B, Veening JG. Effects of acute and chronic apomorphine on sex behavior and copulation-induced neural activation in the male rat. European Journal of Pharmacology. 576: 61-76. PMID 17826765 DOI: 10.1016/J.Ejphar.2007.08.019  0.765
2007 Korosi A, Kozicz T, Richter J, Veening JG, Olivier B, Roubos EW. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord. The Journal of Comparative Neurology. 502: 973-89. PMID 17444496 DOI: 10.1002/Cne.21347  0.58
2007 de Jong TR, Veening JG, Olivier B, Waldinger MD. Oxytocin involvement in SSRI-induced delayed ejaculation: a review of animal studies. The Journal of Sexual Medicine. 4: 14-28. PMID 17233773 DOI: 10.1111/J.1743-6109.2006.00394.X  0.667
2007 Korte SM, Olivier B, Koolhaas JM. A new animal welfare concept based on allostasis. Physiology & Behavior. 92: 422-8. PMID 17174361 DOI: 10.1016/J.Physbeh.2006.10.018  0.504
2007 Kasahara M, Groenink L, Breuer M, Olivier B, Sarnyai Z. Altered behavioural adaptation in mice with neural corticotrophin-releasing factor overexpression. Genes, Brain, and Behavior. 6: 598-607. PMID 17147700 DOI: 10.1111/J.1601-183X.2006.00286.X  0.597
2007 Breuer ME, Groenink L, Oosting RS, Westenberg HG, Olivier B. Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats. Biological Psychiatry. 61: 990-5. PMID 17141743 DOI: 10.1016/J.Biopsych.2006.08.032  0.349
2007 Adriaan Bouwknecht J, Olivier B, Paylor RE. The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse. Neuroscience and Biobehavioral Reviews. 31: 41-59. PMID 16618509 DOI: 10.1016/J.Neubiorev.2006.02.002  0.324
2007 Chan JSW, Oosting RS, Hasselt FNv, Snoeren EMS, Waldinger MD, Olivier B. P.2.04 A rat model predicting sexual side effects of antidepressants European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70049-4  0.348
2006 van den Bergh FS, Bloemarts E, Groenink L, Olivier B, Oosting RS. Delay aversion: effects of 7-OH-DPAT, 5-HT1A/1B-receptor stimulation and D-cycloserine. Pharmacology, Biochemistry, and Behavior. 85: 736-43. PMID 17208285 DOI: 10.1016/J.Pbb.2006.11.007  0.384
2006 Van Bogaert M, Oosting R, Toth M, Groenink L, van Oorschot R, Olivier B. Effects of genetic background and null mutation of 5-HT1A receptors on basal and stress-induced body temperature: modulation by serotonergic and GABAA-ergic drugs. European Journal of Pharmacology. 550: 84-90. PMID 17022970 DOI: 10.1016/J.Ejphar.2006.08.058  0.378
2006 Van den Bergh F, Spronk M, Ferreira L, Bloemarts E, Groenink L, Olivier B, Oosting R. Relationship of delay aversion and response inhibition to extinction learning, aggression, and sexual behaviour. Behavioural Brain Research. 175: 75-81. PMID 16965826 DOI: 10.1016/J.Bbr.2006.08.003  0.328
2006 van Vliet SA, Vanwersch RA, Jongsma MJ, van der Gugten J, Olivier B, Philippens IH. Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects. Behavioural Pharmacology. 17: 453-62. PMID 16940766 DOI: 10.1097/00008877-200609000-00011  0.306
2006 de Jong TR, Veening JG, Waldinger MD, Cools AR, Olivier B. Serotonin and the neurobiology of the ejaculatory threshold. Neuroscience and Biobehavioral Reviews. 30: 893-907. PMID 16529815 DOI: 10.1016/J.Neubiorev.2006.01.001  0.649
2006 Korosi A, Veening JG, Kozicz T, Henckens M, Dederen J, Groenink L, van der Gugten J, Olivier B, Roubos EW. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain. Brain Research. 1072: 46-54. PMID 16423327 DOI: 10.1016/J.Brainres.2005.12.034  0.612
2006 de Jong TR, Snaphaan LJ, Pattij T, Veening JG, Waldinger MD, Cools AR, Olivier B. Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 39-48. PMID 16107310 DOI: 10.1016/J.Euroneuro.2005.06.004  0.752
2006 Olivier B, Chan JS, Pattij T, de Jong TR, Oosting RS, Veening JG, Waldinger MD. Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions? International Journal of Impotence Research. 18: S14-23. PMID 15843803 DOI: 10.1038/Sj.Ijir.3901330  0.761
2005 Waldinger MD, Schweitzer DH, Olivier B. On-demand SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. The Journal of Sexual Medicine. 2: 121-31. PMID 16422915 DOI: 10.1111/J.1743-6109.2005.20112.X  0.386
2005 Pattij T, Olivier B, Waldinger MD. Animal models of ejaculatory behavior. Current Pharmaceutical Design. 11: 4069-77. PMID 16378512 DOI: 10.2174/138161205774913363  0.663
2005 Olivier B, van Oorschot R. 5-HT1B receptors and aggression: a review. European Journal of Pharmacology. 526: 207-17. PMID 16310769 DOI: 10.1016/J.Ejphar.2005.09.066  0.365
2005 Veening JG, Coolen LM, de Jong TR, Joosten HW, de Boer SF, Koolhaas JM, Olivier B. Do similar neural systems subserve aggressive and sexual behaviour in male rats? Insights from c-Fos and pharmacological studies. European Journal of Pharmacology. 526: 226-39. PMID 16263109 DOI: 10.1016/J.Ejphar.2005.09.041  0.747
2005 Olivier B. Serotonergic mechanisms in aggression. Novartis Foundation Symposium. 268: 171-83; discussion 1. PMID 16206880 DOI: 10.1002/0470010703.Ch12  0.379
2005 Pattij T, de Jong TR, Uitterdijk A, Waldinger MD, Veening JG, Cools AR, van der Graaf PH, Olivier B. Individual differences in male rat ejaculatory behaviour: searching for models to study ejaculation disorders. The European Journal of Neuroscience. 22: 724-34. PMID 16101754 DOI: 10.1111/J.1460-9568.2005.04252.X  0.754
2005 de Jong TR, Pattij T, Veening JG, Dederen PJ, Waldinger MD, Cools AR, Olivier B. Effects of chronic paroxetine pretreatment on (+/-)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior. Neuroscience. 134: 1351-61. PMID 16019152 DOI: 10.1016/J.Neuroscience.2005.05.012  0.782
2005 Waldinger MD, Olivier B. Animal models of premature and retarded ejaculation. World Journal of Urology. 23: 115-8. PMID 15940532 DOI: 10.1007/S00345-004-0493-X  0.379
2005 de Jongh R, Geyer MA, Olivier B, Groenink L. The effects of sex and neonatal maternal separation on fear-potentiated and light-enhanced startle. Behavioural Brain Research. 161: 190-6. PMID 15878207 DOI: 10.1016/J.Bbr.2005.02.004  0.327
2005 van der Stelt HM, Breuer ME, Olivier B, Westenberg HG. Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study. Biological Psychiatry. 57: 1061-7. PMID 15860347 DOI: 10.1016/J.Biopsych.2004.12.040  0.379
2005 de Jong TR, Pattij T, Veening JG, Waldinger MD, Cools AR, Olivier B. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine. Psychopharmacology. 179: 509-15. PMID 15719219 DOI: 10.1007/S00213-005-2186-6  0.772
2005 de Jong TR, Pattij T, Veening JG, Dederen PJ, Waldinger MD, Cools AR, Olivier B. Citalopram combined with WAY 100635 inhibits ejaculation and ejaculation-related Fos immunoreactivity. European Journal of Pharmacology. 509: 49-59. PMID 15713429 DOI: 10.1016/J.Ejphar.2004.12.024  0.783
2005 Bogaert MJVV, Groenink L, Oosting RS, Toth M, Olivier B. A35 The Role Of The 5-Ht1A Receptor In The Development Of Anxiety Disorders Behavioural Pharmacology. 16. DOI: 10.1097/00008877-200509001-00108  0.301
2005 Bogaert MJVV, Gerritsen L, Groenink L, Oosting RS, Olivier B. P.2.02 The 5-HT1A and GABAA-benzodiazepine receptors: Effects in behavior and pharmacology in female 5-HT1A knockout mice European Neuropsychopharmacology. 15. DOI: 10.1016/S0924-977X(05)80142-7  0.385
2005 Olivier B, Bogaert Mv, Oorschot Rv, Oosting R, Groenink L. Stress-induced hyperthermia Techniques in the Behavioral and Neural Sciences. 15: 135-155. DOI: 10.1016/S0921-0709(05)80053-7  0.388
2004 Olivier B. Serotonin and aggression. Annals of the New York Academy of Sciences. 1036: 382-92. PMID 15817750 DOI: 10.1196/Annals.1330.022  0.357
2004 Waldinger MD, Zwinderman AH, Olivier B. On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. European Urology. 46: 510-5; discussion 51. PMID 15363569 DOI: 10.1016/J.Eururo.2004.05.005  0.305
2004 Veening JG, Bouwknecht JA, Joosten HJ, Dederen PJ, Zethof TJ, Groenink L, van der Gugten J, Olivier B. Stress-induced hyperthermia in the mouse: c-fos expression, corticosterone and temperature changes. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 699-707. PMID 15276696 DOI: 10.1016/J.Pnpbp.2004.05.007  0.614
2004 Bouwknecht JA, van der Gugten J, Groenink L, Olivier B, Paylor RE. Behavioral and physiological mouse models for anxiety: effects of flesinoxan in 129S6/SvEvTac and C57BL/6J mice. European Journal of Pharmacology. 494: 45-53. PMID 15194450 DOI: 10.1016/J.Ejphar.2004.04.037  0.406
2004 Bouwknecht JA, van der Gugten J, Groenink L, Olivier B, Paylor RE. Effects of repeated testing in two inbred strains on flesinoxan dose-response curves in three mouse models for anxiety. European Journal of Pharmacology. 494: 35-44. PMID 15194449 DOI: 10.1016/J.Ejphar.2004.04.036  0.37
2004 Kozicz T, Korosi A, Korsman C, Tilburg-Ouwens D, Groenink L, Veening J, van Der Gugten J, Roubos E, Olivier B. Urocortin expression in the Edinger-Westphal nucleus is down-regulated in transgenic mice over-expressing neuronal corticotropin-releasing factor. Neuroscience. 123: 589-94. PMID 14706771 DOI: 10.1016/J.Neuroscience.2003.10.042  0.609
2004 Pattij T, Broersen LM, Peter S, Olivier B. Impulsive-like behavior in differential-reinforcement-of-low-rate 36 s responding in mice depends on training history. Neuroscience Letters. 354: 169-71. PMID 14698465 DOI: 10.1016/J.Neulet.2003.10.004  0.631
2004 van der Stelt HM, Broersen LM, Olivier B, Westenberg HG. Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats. Psychopharmacology. 172: 137-44. PMID 14647968 DOI: 10.1007/S00213-003-1632-6  0.34
2003 Groenink L, van Bogaert MJ, van der Gugten J, Oosting RS, Olivier B. 5-HT1A receptor and 5-HT1B receptor knockout mice in stress and anxiety paradigms. Behavioural Pharmacology. 14: 369-83. PMID 14501251 DOI: 10.1097/01.Fbp.0000087737.21047.75  0.348
2003 De Groote L, Olivier B, Westenberg HG. Role of 5-HT1B receptors in the regulation of extracellular serotonin and dopamine in the dorsal striatum of mice. European Journal of Pharmacology. 476: 71-7. PMID 12969751 DOI: 10.1016/S0014-2999(03)02154-X  0.362
2003 Dirks A, Groenink L, Westphal KG, Olivier JD, Verdouw PM, van der Gugten J, Geyer MA, Olivier B. Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1790-8. PMID 12865891 DOI: 10.1038/Sj.Npp.1300256  0.326
2003 Pattij T, Broersen LM, van der Linde J, Groenink L, van der Gugten J, Maes RA, Olivier B. Operant learning and differential-reinforcement-of-low-rate 36-s responding in 5-HT1A and 5-HT1B receptor knockout mice. Behavioural Brain Research. 141: 137-45. PMID 12742250 DOI: 10.1016/S0166-4328(02)00345-5  0.629
2003 de Groote L, Klompmakers AA, Olivier B, Westenberg HG. Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade. Psychopharmacology. 167: 153-8. PMID 12644890 DOI: 10.1007/S00213-002-1371-0  0.365
2003 Groenink L, Pattij T, De Jongh R, Van der Gugten J, Oosting RS, Dirks A, Olivier B. 5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety. European Journal of Pharmacology. 463: 185-97. PMID 12600710 DOI: 10.1016/S0014-2999(03)01281-0  0.632
2003 Olivier B, Zethof T, Pattij T, van Boogaert M, van Oorschot R, Leahy C, Oosting R, Bouwknecht A, Veening J, van der Gugten J, Groenink L. Stress-induced hyperthermia and anxiety: pharmacological validation. European Journal of Pharmacology. 463: 117-32. PMID 12600705 DOI: 10.1016/S0014-2999(03)01326-8  0.749
2003 de Groote L, Klompmakers AA, Olivier B, Westenberg HG. An evaluation of the effect of NAS-181, a new selective 5-HT(1B) receptor antagonist, on extracellular 5-HT levels in rat frontal cortex. Naunyn-Schmiedeberg's Archives of Pharmacology. 367: 89-94. PMID 12595948 DOI: 10.1007/S00210-002-0685-0  0.378
2002 Dirks A, Groenink L, Bouwknecht JA, Hijzen TH, Van Der Gugten J, Ronken E, Verbeek JS, Veening JG, Dederen PJ, Korosi A, Schoolderman LF, Roubos EW, Olivier B. Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations. The European Journal of Neuroscience. 16: 1751-60. PMID 12431228 DOI: 10.1046/J.1460-9568.2002.02245.X  0.607
2002 Pattij T, Groenink L, Hijzen TH, Oosting RS, Maes RA, van der Gugten J, Olivier B. Autonomic changes associated with enhanced anxiety in 5-HT(1A) receptor knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 380-90. PMID 12225695 DOI: 10.1016/S0893-133X(02)00317-2  0.649
2002 de Groote L, Olivier B, Westenberg HG. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice. Psychopharmacology. 162: 419-24. PMID 12172696 DOI: 10.1007/S00213-002-1117-Z  0.342
2002 Pattij T, Groenink L, Oosting RS, van der Gugten J, Maes RA, Olivier B. GABA(A)-benzodiazepine receptor complex sensitivity in 5-HT(1A) receptor knockout mice on a 129/Sv background. European Journal of Pharmacology. 447: 67-74. PMID 12106804 DOI: 10.1016/S0014-2999(02)01893-9  0.639
2002 Dirks A, Fish EW, Kikusui T, van der Gugten J, Groenink L, Olivier B, Miczek KA. Effects of corticotropin-releasing hormone on distress vocalizations and locomotion in maternally separated mouse pups. Pharmacology, Biochemistry, and Behavior. 72: 993-9. PMID 12062591 DOI: 10.1016/S0091-3057(02)00809-2  0.325
2002 Groenink L, Dirks A, Verdouw PM, Schipholt Ml, Veening JG, van der Gugten J, Olivier B. HPA axis dysregulation in mice overexpressing corticotropin releasing hormone. Biological Psychiatry. 51: 875-81. PMID 12022960 DOI: 10.1016/S0006-3223(02)01334-3  0.612
2002 Olivier B, Broersen LM, Slangen JL. 5-HT3 receptor ligands lack discriminative stimulus properties. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 26: 463-71. PMID 11999896 DOI: 10.1016/S0278-5846(01)00290-1  0.362
2002 Dirks A, Groenink L, Schipholt MI, van der Gugten J, Hijzen TH, Geyer MA, Olivier B. Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone. Biological Psychiatry. 51: 583-90. PMID 11950460 DOI: 10.1016/S0006-3223(01)01323-3  0.318
2002 De Groote L, Olivier B, Westenberg HG. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice. European Journal of Pharmacology. 439: 93-100. PMID 11937097 DOI: 10.1016/S0014-2999(02)01417-6  0.347
2002 Olivier B, Bouwknecht JA, Pattij T, Leahy C, van Oorschot R, Zethof TJ. GABAA-benzodiazepine receptor complex ligands and stress-induced hyperthermia in singly housed mice. Pharmacology, Biochemistry, and Behavior. 72: 179-88. PMID 11900786 DOI: 10.1016/S0091-3057(01)00759-6  0.637
2002 Waldinger MD, van De Plas A, Pattij T, van Oorschot R, Coolen LM, Veening JG, Olivier B. The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology. 160: 283-9. PMID 11889497 DOI: 10.1007/S00213-001-0980-3  0.76
2002 de Jongh R, Groenink L, van Der Gugten J, Olivier B. The light-enhanced startle paradigm as a putative animal model for anxiety: effects of chlordiazepoxide, flesinoxan and fluvoxamine. Psychopharmacology. 159: 176-80. PMID 11862346 DOI: 10.1007/S002130100914  0.361
2002 Bouwknecht JA, Hijzen TH, van der Gugten J, Maes RA, Hen R, Olivier B. 5-HT(1B) receptor knockout mice show no adaptive changes in 5-HT(1A) receptor function as measured telemetrically on body temperature and heart rate responses. Brain Research Bulletin. 57: 93-102. PMID 11827741 DOI: 10.1016/S0361-9230(01)00640-2  0.376
2002 Olivier B, Groenink L, Gugten JVd. 5-HT1A receptor knockout mice and anxiety: Is the GABAA-benzodiazepine receptor complex involved? European Neuropsychopharmacology. 12: 153-154. DOI: 10.1016/S0924-977X(02)80103-1  0.337
2001 Bouwknecht JA, van der Gugten J, Hijzen TH, Maes RA, Hen R, Olivier B. Male and female 5-HT(1B) receptor knockout mice have higher body weights than wildtypes. Physiology & Behavior. 74: 507-16. PMID 11790410 DOI: 10.1016/S0031-9384(01)00589-3  0.362
2001 Olivier B, Pattij T, Wood SJ, Oosting R, Sarnyai Z, Toth M. The 5-HT(1A) receptor knockout mouse and anxiety. Behavioural Pharmacology. 12: 439-50. PMID 11742137 DOI: 10.1097/00008877-200111000-00004  0.74
2001 Olivier B, Leahy C, Mullen T, Paylor R, Groppi VE, Sarnyai Z, Brunner D. The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics? Psychopharmacology. 156: 284-90. PMID 11549230 DOI: 10.1007/S002130100828  0.595
2001 Meer Mvd, Baumans V, Olivier B, Zutphen BLMv. Impact of transgenic procedures on behavioral and physiological responses in postweaning mice. Physiology & Behavior. 73: 133-143. PMID 11399305 DOI: 10.1016/S0031-9384(01)00461-9  0.306
2001 Waldinger MD, Zwinderman AH, Olivier B. Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. Journal of Clinical Psychopharmacology. 21: 293-297. PMID 11386492 DOI: 10.1097/00004714-200106000-00007  0.333
2001 Pattij T, Hijzen TH, Groenink L, Oosting RS, van der Gugten J, Maes RA, Hen R, Olivier B. Stress-induced hyperthermia in the 5-HT(1A) receptor knockout mouse is normal. Biological Psychiatry. 49: 569-74. PMID 11297713 DOI: 10.1016/S0006-3223(00)01022-2  0.649
2001 Bouwknecht JA, Hijzen TH, van der Gugten J, Maes RA, Hen R, Olivier B. Absence of 5-HT(1B) receptors is associated with impaired impulse control in male 5-HT(1B) knockout mice. Biological Psychiatry. 49: 557-68. PMID 11297712 DOI: 10.1016/S0006-3223(00)01018-0  0.383
2001 Bouwknecht JA, van der Gugten J, Hijzen TH, Maes RA, Hen R, Olivier B. Corticosterone responses in 5-HT1B receptor knockout mice to stress or 5-HT1A receptor activation are normal. Psychopharmacology. 153: 484-90. PMID 11243496 DOI: 10.1007/S002130000598  0.37
2001 Dirks A, Pattij T, Bouwknecht JA, Westphal TT, Hijzen TH, Groenink L, van der Gugten J, Oosting RS, Hen R, Geyer MA, Olivier B. 5-HT1B receptor knockout, but not 5-HT1A receptor knockout mice, show reduced startle reactivity and footshock-induced sensitization, as measured with the acoustic startle response. Behavioural Brain Research. 118: 169-78. PMID 11164514 DOI: 10.1016/S0166-4328(00)00326-0  0.636
2001 Sibug RM, Compaan JC, Meijer OC, Van der Gugten J, Olivier B, De Kloet ER. Effects of flesinoxan on corticosteroid receptor expression in the rat hippocampus. European Journal of Pharmacology. 404: 111-9. PMID 10980269 DOI: 10.1016/S0014-2999(00)00605-1  0.376
2001 Groenink L, Verdouw PM, Oorschot Rv, Olivier B. UNIT 5.18 Models of Anxiety: Ultrasonic Vocalizations of Isolated Rat Pups Current Protocols in Pharmacology. DOI: 10.1002/0471141755.Ph0518S05  0.345
2000 Gommans J, Hijzen TH, Maes RA, Olivier B. Two-lever drug-drug discrimination with the 5-HT1 receptor agonists flesinoxan and eltoprazine. The International Journal of Neuropsychopharmacology. 3: 221-228. PMID 11343599 DOI: 10.1017/S1461145700001991  0.372
2000 Pattij T, Hijzen TH, Gommans J, Maes RA, Olivier B. Effects of drug discrimination history on anti-punishment properties of chlordiazepoxide in rats. Pharmacology, Biochemistry, and Behavior. 67: 621-7. PMID 11164094 DOI: 10.1016/S0091-3057(00)00446-9  0.604
2000 Bouwknecht JA, Hijzen TH, van der Gugten J, Maes RA, Hen R, Olivier B. Ethanol intake is not elevated in male 5-HT(1B) receptor knockout mice. European Journal of Pharmacology. 403: 95-8. PMID 10969149 DOI: 10.1016/S0014-2999(00)00527-6  0.301
2000 Groenink L, Joordens RJE, Hijzen TH, Dirks A, Olivier B. Infusion of flesinoxan into the amygdala blocks the fear-potentiated startle. Neuroreport. 11: 2285-2288. PMID 10923686 DOI: 10.1097/00001756-200007140-00043  0.342
2000 Bouwknecht JA, Hijzen TH, Gugten Jvd, Maes RAA, Olivier B. Stress-induced hyperthermia in mice: effects of flesinoxan on heart rate and body temperature. European Journal of Pharmacology. 400: 59-66. PMID 10913585 DOI: 10.1016/S0014-2999(00)00387-3  0.307
2000 Broersen LM, Abbate F, Feenstra MG, de Bruin JP, Heinsbroek RP, Olivier B. Prefrontal dopamine is directly involved in the anxiogenic interoceptive cue of pentylenetetrazol but not in the interoceptive cue of chlordiazepoxide in the rat. Psychopharmacology. 149: 366-76. PMID 10867964 DOI: 10.1007/S002130000390  0.358
2000 Olivier B, Van Wijngaarden I, Soudijn W. 5-HT3 receptor antagonists and anxiety; A preclinical and clinical review European Neuropsychopharmacology. 10: 77-95. PMID 10706989 DOI: 10.1016/S0924-977X(99)00065-6  0.396
2000 Gommans J, Hijzen TH, Maes RAA, Olivier B. Discriminative stimulus properties of alprazolam. Psychopharmacology. 148: 146-152. PMID 10663429 DOI: 10.1007/S002130050036  0.318
2000 Philippens IHCHM, Melchers BPC, Olivier B, Bruijnzeel PLB. Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs. Pharmacology, Biochemistry and Behavior. 65: 175-182. PMID 10638651 DOI: 10.1016/S0091-3057(99)00171-9  0.339
1999 Olivier B, Herremans A, Mos J, Drimmelen MV, Tulp M, Oorschot RV, Hijzen T. Discriminative stimulus properties of eltoprazine in the pigeon. Pharmacology, Biochemistry and Behavior. 64: 421-427. PMID 10515324 DOI: 10.1016/S0091-3057(99)00073-8  0.355
1999 Gommans J, Hijzen TH, Pattij T, van der Gugten J, Olivier B. Discriminative stimulus properties of mCPP and alprazolam are not mediated by anxiety. Pharmacology, Biochemistry, and Behavior. 64: 385-7. PMID 10515318 DOI: 10.1016/S0091-3057(99)00062-3  0.64
1999 Olivier B, Gommans J, Gugten JVD, Bouwknecht JA, Herremans AHJ, Patty T, Hijzen TH. Stimulus properties of the selective 5-HT reuptake inhibitor fluvoxamine in conditioned taste aversion procedures. Pharmacology, Biochemistry and Behavior. 64: 213-220. PMID 10515294 DOI: 10.1016/S0091-3057(99)00082-9  0.326
1999 Olivier B, Soudijn W, Van Wijngaarden I. The 5-HT(1A) receptor and its ligands: Structure and function Progress in Drug Research. 52: 103-165. PMID 10396127 DOI: 10.1007/978-3-0348-8730-4_3  0.353
1999 Bruijnzeel AW, Stam R, Compaan JC, Croiset G, Akkermans LMA, Olivier B, Wiegant VM. Long-term sensitization of Fos-responsivity in the rat central nervous system after a single stressful experience. Brain Research. 819: 15-22. PMID 10082856 DOI: 10.1016/S0006-8993(98)01350-X  0.328
1999 Mos J, Mollet I, Tolboom JTBM, Waldinger MD, Olivier B. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat European Neuropsychopharmacology. 9: 123-135. PMID 10082238 DOI: 10.1016/S0924-977X(98)00015-7  0.383
1999 Olivier B. Serotonin Receptors In Drug Discrimination: Antidepressants And Anxiolytics Behavioural Pharmacology. 10. DOI: 10.1097/00008877-199908001-00172  0.341
1998 Gommans J, Bouwknecht JA, Hijzen TH, Berendsen HHG, Broekkamp CLE, Maes RAA, Olivier B. Stimulus properties of fluvoxamine in a conditioned taste aversion procedure. Psychopharmacology. 140: 496-502. PMID 9888626 DOI: 10.1007/S002130050794  0.369
1998 Olivier B, Molewijk HE, van der Heyden JA, van Oorschot R, Ronken E, Mos J, Miczek KA. Ultrasonic vocalizations in rat pups: effects of serotonergic ligands. Neuroscience and Biobehavioral Reviews. 23: 215-27. PMID 9884114 DOI: 10.1016/S0149-7634(98)00022-0  0.4
1998 Joordens RJE, Hijzen TH, Olivier B. The anxiolytic effect on the fear-potentiated startle is not due to a non-specific disruption. Life Sciences. 63: 2227-2232. PMID 9870708 DOI: 10.1016/S0024-3205(98)00507-4  0.313
1998 Joordens RJE, Hijzen TH, Olivier B. The effects of 5-HT1A receptor agonists, 5-HT1A receptor antagonists and their interaction on the fear-potentiated startle response. Psychopharmacology. 139: 383-390. PMID 9809859 DOI: 10.1007/S002130050729  0.365
1998 Olivier B, Molewijk E, Oorschot Rv, Heyden Jvd, Ronken E, Mos J. Rat pup ultrasonic vocalization: effects of benzodiazepine receptor ligands European Journal of Pharmacology. 358: 117-128. PMID 9808260 DOI: 10.1016/S0014-2999(98)00603-7  0.341
1998 Olivier B, Oorschot RV, Waldinger MD. Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour International Clinical Psychopharmacology. 13. PMID 9728669 DOI: 10.1097/00004850-199807006-00003  0.44
1998 Sibug RM, Compaan JC, Meijer OC, Van der Gugten J, Olivier B, De Kloet ER. Flesinoxan treatment reduces 5-HT1A receptor mRNA in the dentate gyrus independently of high plasma corticosterone levels. European Journal of Pharmacology. 353: 207-14. PMID 9726650 DOI: 10.1016/S0014-2999(98)00417-8  0.389
1998 Veening JG, Coolen LM, Spooren WJ, Joosten H, van Oorschot R, Mos J, Ronken E, Olivier B. Patterns of c-fos expression induced by fluvoxamine are different after acute vs. chronic oral administration. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 8: 213-26. PMID 9716316 DOI: 10.1016/S0924-977X(97)00072-2  0.641
1998 Gommans J, Hijzen TH, Maes RAA, Olivier B. Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action. Psychopharmacology. 137: 292-302. PMID 9683007 DOI: 10.1007/S002130050622  0.36
1998 Waldinger MD, Berendsen HHG, Blok BFM, Olivier B, Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system Behavioural Brain Research. 92: 111-118. PMID 9638953 DOI: 10.1016/S0166-4328(97)00183-6  0.342
1998 Philippens IHCHM, Busker RW, Wolthuis OL, Olivier B, Bruijnzeel PLB, Melchers BPC. Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects. Pharmacology, Biochemistry and Behavior. 59: 1061-1067. PMID 9586868 DOI: 10.1016/S0091-3057(97)00511-X  0.315
1998 Olivier B, Zethof TJJ, Ronken E, Heyden JAMvd. Anxiolytic effects of flesinoxan in the stress-induced hyperthermia paradigm in singly-housed mice are 5-HT1A receptor mediated European Journal of Pharmacology. 342: 177-182. PMID 9548383 DOI: 10.1016/S0014-2999(97)01482-9  0.351
1998 Pattij T, Hijzen TH, Olivier B. ANTIPUNISHMENT EFFECTS AND DISCRIMINATIVE STIMULUS EFFECTS OF ANXIOLYTIC DRUGS MEASURED DURING THE SAME SESSION Behavioural Pharmacology. 9: S118. DOI: 10.1097/00008877-199808000-00273  0.582
1998 Herremans AH, van der Heyden JA, van Drimmelen M, Olivier B. THE 5-HT1A RECEPTOR AGONIST FLESINOXAN SHARES DISCRIMINATIVE STIMULUS PROPERTIES WITH SOME 5-HT2 RECEPTOR ANTAGONISTS Behavioural Pharmacology. 9: S111. DOI: 10.1016/S0091-3057(99)00051-9  0.37
1997 Philippens IHCHM, Olivier B, Melchers BPC. Effects of Physostigmine on the Startle in Guinea Pigs: Two Mechanisms Involved Pharmacology, Biochemistry and Behavior. 58: 909-913. PMID 9408195 DOI: 10.1016/S0091-3057(97)00025-7  0.32
1997 Coolen LM, Olivier B, Peters HJ, Veening JG. Demonstration of ejaculation-induced neural activity in the male rat brain using 5-HT1A agonist 8-OH-DPAT. Physiology & Behavior. 62: 881-91. PMID 9284512 DOI: 10.1016/S0031-9384(97)00258-8  0.661
1997 Heyden JAMVD, Zethof TJJ, Olivier B. Stress-Induced Hyperthermia in Singly Housed Mice Physiology & Behavior. 62: 463-470. PMID 9272651 DOI: 10.1016/S0031-9384(97)00157-1  0.327
1997 Gommans J, Hijzen TH, Maes RA, Olivier B. Discriminative stimulus properties of eltoprazine Life Sciences. 61: 11-19. PMID 9200664 DOI: 10.1016/S0024-3205(97)00352-4  0.336
1997 Groenink L, Gugten JVd, Compaan JC, Maes RAA, Olivier B. Flesinoxan pretreatment differentially affects corticosterone, prolactin and behavioural responses to a flesinoxan challenge. Psychopharmacology. 131: 93-100. PMID 9181641 DOI: 10.1007/S002130050270  0.373
1997 Mos J, Hest AV, Drimmelen MV, Herremans AHJ, Olivier B. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons European Journal of Pharmacology. 325: 145-153. PMID 9163561 DOI: 10.1016/S0014-2999(97)00131-3  0.369
1997 King CM, Gommans J, Joordens RJ, Hijzen TH, Maes RA, Olivier B. Effects of 5-HT1A receptor ligands in a modified Geller-Seifter conflict model in the rat. European Journal of Pharmacology. 325: 121-8. PMID 9163558 DOI: 10.1016/S0014-2999(97)00114-3  0.379
1997 Compaan JC, Groenink L, Gugten JVd, Maes RAA, Olivier B. Pretreatment with 5-HT1A receptor agonist flesinoxan attenuates Fos protein in rat hypothalamus. European Journal of Pharmacology. 324: 161-168. PMID 9145767 DOI: 10.1016/S0014-2999(97)00071-X  0.367
1997 Herremans AHJ, Hijzen TH, Olivier B. Effects of cholinergic drug infusions into the dorsal part of the medial prefrontal cortex on delayed conditional discrimination performance in the rat. Behavioural Brain Research. 84: 291-299. PMID 9079794 DOI: 10.1016/S0166-4328(97)83336-0  0.304
1997 Veening J, Coolen L, Spooren W, Mos J, Ronken E, Olivier B. Oral administration of fluvoxamine induces Fos-IR in the male rat brain Behavioural Pharmacology. 8: 666. DOI: 10.1097/00008877-199711000-00077  0.62
1997 Joordens R, King C, Hijzen T, Olivier B. The effect of intra-amygdaloid micro-injections of the 5-HT1A receptor agonist flesinoxan on the fear-potentiated startle response Behavioural Pharmacology. 8: 651. DOI: 10.1097/00008877-199711000-00045  0.34
1997 Ronken E, Olivier B. The 5-HT2-type receptor family Pharmacochemistry Library. 27: 199-214. DOI: 10.1016/S0165-7208(97)80014-1  0.398
1997 Mos J, Olivier B. 5-HT1A behavioural models Pharmacochemistry Library. 27: 73-79. DOI: 10.1016/S0165-7208(97)80007-4  0.385
1996 Groenink L, Mos J, Gugten JVD, Olivier B. The 5-HT1A receptor is not involved in emotional stress-induced rises in stress hormones Pharmacology, Biochemistry and Behavior. 55: 303-308. PMID 8951969 DOI: 10.1016/S0091-3057(96)00088-3  0.348
1996 Compaan JC, Groenink L, Gugten Jvd, Maes RAA, Olivier B. 5-HT1A receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamus. European Journal of Neuroscience. 8: 2340-2347. PMID 8950098 DOI: 10.1111/J.1460-9568.1996.Tb01197.X  0.358
1996 Molewijk HE, Hartog K, Poel AMvd, Mos J, Olivier B. Reduction of guinea pig pup isolation calls by anxiolytic and antidepressant drugs. Psychopharmacology. 128: 31-38. PMID 8944403 DOI: 10.1007/S002130050106  0.405
1996 Broersen LM, Heinsbroek RP, de Bruin JP, Olivier B. Effects of local application of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition. Biological Psychiatry. 40: 1083-90. PMID 8931910 DOI: 10.1016/S0006-3223(95)00595-1  0.345
1996 Mos J, Aken HHMv, Oorschot Rv, Olivier B. Chronic treatment with eltoprazine does not lead to tolerance in its anti-aggressive action, in contrast to haloperidol European Neuropsychopharmacology. 6: 1-7. PMID 8866931 DOI: 10.1016/0924-977X(95)00051-P  0.343
1996 Joordens RJE, Hijzen TH, Peeters BWMM, Olivier B. Fear-potentiated startle response is remarkably similar in two laboratories. Psychopharmacology. 126: 104-109. PMID 8856828 DOI: 10.1007/Bf02246344  0.307
1996 Groenink L, Gugten Jvd, Zethof TJJ, Heyden JAMvd, Olivier B. Neuroendocrine effects of diazepam and flesinoxan in the stress-induced hyperthermia test in mice Pharmacology, Biochemistry and Behavior. 54: 249-254. PMID 8728565 DOI: 10.1016/0091-3057(95)02177-9  0.302
1996 Herremans AHJ, Hijzen TH, Welborn PFE, Olivier B, Slangen JL. Effects of infusion of cholinergic drugs into the prefrontal cortex area on delayed matching to position performance in the rat Brain Research. 711: 102-111. PMID 8680852 DOI: 10.1016/0006-8993(95)01404-7  0.34
1996 Molewijk HE, van der Poel AM, Olivier B. The ambivalent behaviour "stretched approach posture" in the rat as a paradigm to characterize anxiolytic drugs. Psychopharmacology. 121: 81-90. PMID 8539344 DOI: 10.1007/Bf02245594  0.388
1996 MOLEWIJK HE, VAN DER POEL AM, MOS J, OLIVIER B. EFFECTS OF NEGATIVE ALLOSTERIC MODULATORS OF GABAA RECEPTORS ON COMPLEX BEHAVIORAL PROCESSES IN MONKEYS Behavioural Pharmacology. 7: 70. DOI: 10.1097/00008877-199605001-00159  0.313
1996 Jankowska E, Iwinska K, Stefanski R, Biekowskip, Kostowskiw, Joordens R, King C, Hijzen TH, Olivier B. Combined Cholinergic And 5-Ht2 Receptor Stimulation Suppresses Age-Related Neocortical Eeg Arousal Defect Behavioural Pharmacology. 7: 53. DOI: 10.1097/00008877-199605001-00121  0.323
1996 Herremans AHJ, Heyden JAMvd, Ronken E, Olivier B. A drug discrimination rocedure in the pigeon confirms the in vitro agonistic action of flesinoxan on the 5-HT1A receptor European Neuropsychopharmacology. 6. DOI: 10.1016/0924-977X(96)83069-0  0.321
1996 Bouwknecht JA, Gommans J, Hijzen TH, Berendsen HHG, Olivier B. Flesinoxan, a selective 5-HT1A receptor agonist, familiarizes with fluvoxamine and fluoxetine in a conditioned taste aversion procedure in mice European Neuropsychopharmacology. 6. DOI: 10.1016/0924-977X(96)83023-9  0.342
1996 Mos J, Cramer WCM, Heyden JAMvd, Molewijk HE, Olivier B. Efficacy of the full 5-HT1A receptor agonist flesinoxan compared with other 5-HT1A agonists in animal models for anxiety European Neuropsychopharmacology. 6. DOI: 10.1016/0924-977X(96)82972-5  0.344
1996 Mos J, Ronken E, Cramer WCC, Molewijk eM, Heyden JAMvd, Olivier B. A comparison of the full 5-HT1A agonist flesinoxan with other 5-HT1A agonists: Effects on behaviour and a quantification of (partial) agonism on cells European Neuropsychopharmacology. 6. DOI: 10.1016/0924-977X(96)82967-1  0.323
1996 Olivier B, Groenink L, Hijzen T, Gugten Jvd. 5-HT1A receptors, anxiety and stress: Behavioural, neuroendocrine and physiological interfaces European Neuropsychopharmacology. 6. DOI: 10.1016/0924-977X(96)82904-X  0.32
1995 Zethof TJJ, Heyden JAMVD, Tolboom JTBM, Olivier B. Stress-induced hyperthermia as a putative anxiety model European Journal of Pharmacology. 294: 125-135. PMID 8788424 DOI: 10.1016/0014-2999(95)00520-X  0.354
1995 Olivier B, Mos J, van Oorschot R, Hen R. Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry. 28: 80-90. PMID 8614705 DOI: 10.1055/S-2007-979624  0.424
1995 Gommans J, Hijzen TH, Maes RA, Mos J, Olivier B. Discriminative stimulus properties of flesinoxan: effects of enantiomers, (S)-UH301 and WAY-100635 European Journal of Pharmacology. 284: 135-140. PMID 8549617 DOI: 10.1016/0014-2999(95)00391-W  0.332
1995 Broersen LM, Heinsbroek RP, de Bruin JP, Uylings HB, Olivier B. The role of the medial prefrontal cortex of rats in short-term memory functioning: further support for involvement of cholinergic, rather than dopaminergic mechanisms. Brain Research. 674: 221-9. PMID 7796100 DOI: 10.1016/0006-8993(95)00025-L  0.356
1995 Molewijk HE, van der Poel AM, Mos J, van der Heyden JA, Olivier B. Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs. Psychopharmacology. 117: 32-40. PMID 7724700 DOI: 10.1007/Bf02245095  0.406
1995 Groenink L, Gugten JVd, Mos J, Maes RAA, Olivier B. The corticosterone-enhancing effects of the 5-HT1A receptor antagonist, (S)-UH301, are not mediated by the 5-HT1A receptor European Journal of Pharmacology. 272: 177-183. PMID 7713161 DOI: 10.1016/0014-2999(94)00645-N  0.321
1995 Herremans AH, Hijzen TH, Olivier B, Slangen JL. Cholinergic drug effects on a delayed conditional discrimination task in the rat. Behavioral Neuroscience. 109: 426-35. PMID 7662153 DOI: 10.1037//0735-7044.109.3.426  0.331
1995 Groenink L, Gugten JVd, Verdouw PM, Maes RAA, Olivier B. The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effects. European Journal of Pharmacology. 280: 185-193. PMID 7589185 DOI: 10.1016/0014-2999(95)00209-4  0.309
1995 Van Dijken HH, Tilders FJ, Olivier B, Mos J. Effects of anxiolytic and antidepressant drugs on long-lasting behavioural deficits resulting from one short stress experience in male rats. Psychopharmacology. 109: 395-402. PMID 1365853 DOI: 10.1007/Bf02247714  0.355
1995 Broersen LM, Heinsbroek RPw, Bruin JPcd, Laan Jb, Joosten RNjma, Olivier B. Local pharmacological manipulations of prefrontal dopamine affect conflict behaviour in rats. Behavioural Pharmacology. 6: 395-404. DOI: 10.1097/00008877-199506000-00010  0.355
1995 Herremans AHJ, Hijzen TH, Olivier B, Slangen JL. Benzodiazepine receptor ligands have no specific action on working memory in a delayed conditional discrimination task in rats. Behavioural Pharmacology. 6: 238-244. DOI: 10.1097/00008877-199504000-00004  0.302
1994 Zethof TJJ, Heyden JAMVD, Tolboom JTBM, Olivier B. Stress-induced hyperthermia in mice: a methodological study. Physiology & Behavior. 55: 109-115. PMID 8140153 DOI: 10.1016/0031-9384(94)90017-5  0.304
1994 Ybema CE, Olivier B, Mos J, Tulp MTM, Slangen JL. Adrenoceptors and dopamine receptors are not involved in the discriminative stimulus effect of the 5-HT1A receptor agonist flesinoxan. European Journal of Pharmacology. 256: 141-147. PMID 8050464 DOI: 10.1016/0014-2999(94)90238-0  0.339
1994 Groenink L, Gugten JVD, Mos J, Maes RAA, Olivier B. (S)-UH301, a silent 5-HT1A receptor antagonist, enhances plasma corticosterone levels in the rat. Life Sciences. 55: 99-103. PMID 8035646 DOI: 10.1016/0024-3205(94)00654-7  0.367
1994 Ybema CE, Slangen JL, Olivier B. Discriminative stimulus effect of flesinoxan : effects of 5-HT1A antagonists and PCPA Pharmacology, Biochemistry and Behavior. 47: 957-962. PMID 8029269 DOI: 10.1016/0091-3057(94)90303-4  0.379
1994 Olivier B, Molewijk E, Oorschot Rv, Poel Gvd, Zethof T, Heyden Jvd, Mos J. New animal models of anxiety European Neuropsychopharmacology. 4: 93-102. PMID 7919948 DOI: 10.1016/0924-977X(94)90002-7  0.416
1994 Broersen LM, Heinsbroek RP, de Bruin JP, Joosten RN, van Hest A, Olivier B. Effects of local application of dopaminergic drugs into the dorsal part of the medial prefrontal cortex of rats in a delayed matching to position task: comparison with local cholinergic blockade. Brain Research. 645: 113-22. PMID 7914812 DOI: 10.1016/0006-8993(94)91644-6  0.335
1994 Groenink L, Gugten Jvd, Zethof T, Heyden Jvd, Olivier B. Stress-induced hyperthermia in mice: hormonal correlates Physiology & Behavior. 56: 747-749. PMID 7800743 DOI: 10.1016/0031-9384(94)90237-2  0.302
1994 Olivier B, Groenink L, Molewijk HE. Experimental models of human anxiety — efficacy of antipanic agents European Neuropsychopharmacology. 4: 268-270. DOI: 10.1016/0924-977X(94)90086-8  0.31
1993 Mos J, Olivier B, Poth M, Oorschot RV, Aken HV. The effects of dorsal raphe administration of eltoprazine, TFMPP and 8-OH-DPAT on resident intruder aggression in the rat. European Journal of Pharmacology. 238: 411-415. PMID 8405111 DOI: 10.1016/0014-2999(93)90877-K  0.402
1993 Olivier B, Bosch L, Hest AV, Heyden JVD, Mos J, Poel GVD, Schipper J, Tulp M. Preclinical evidence on the psychotropic profile of fluvoxamine Pharmacopsychiatry. 26: 2-9. PMID 8378418 DOI: 10.1055/S-2007-1014370  0.365
1993 Poel AMvd, Molewijk HE, Vedder AW, Mos J, Olivier B. Ultrasonic calls of male rats in anticipation of aversive stimulation: Pharmacological validation as an anxiety model European Neuropsychopharmacology. 3: 369. DOI: 10.1016/0924-977X(93)90156-G  0.324
1992 Olivier B, Schipper J, Heyden JAMvd, Hest Av, Mos J, Tulp MTM. Preclinical evidence for the role of serotonin receptor-subtypes in depression. Acta Neuropsychiatrica. 4: 40-45. PMID 26956533 DOI: 10.1017/S0924270800034888  0.363
1992 Mos J, Olivier B, Poth M, Aken Hv. The effects of intraventricular administration of eltoprazine, 1-(3-trifluoromethylphenyl)piperazine hydrochloride and 8-hydroxy-2-(di-n-propylamino)tetralin on resident intruder aggression in the rat. European Journal of Pharmacology. 212: 295-298. PMID 1534769 DOI: 10.1016/0014-2999(92)90348-8  0.395
1992 Olivier B, Mos J. Rodent models of aggressive behavior and serotonergic drugs. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 16: 847-870. PMID 1513929 DOI: 10.1016/0278-5846(92)90104-M  0.401
1992 Hest AV, Hijzen TH, Slangen JL, Olivier B. Assessment of the stimulus properties of anxiolytic drugs by means of the conditioned taste aversion procedure. Pharmacology, Biochemistry and Behavior. 42: 487-495. PMID 1357674 DOI: 10.1016/0091-3057(92)90144-5  0.303
1992 Hest AV, Drimmelen MV, Olivier B. Discriminative Stimulus Effects Of 5-Ht1A Receptor Ligands In The Rat Behavioural Pharmacology. 3: 527. DOI: 10.1097/00008877-199210000-00014  0.331
1992 Olivier B, Mos J, Poel AM, Heyden JV, Tulp M, Schipper I. Behavioural Pharmacology Of The 5-Ht1A Agonist Flesinoxan Behavioural Pharmacology. 3: 38. DOI: 10.1097/00008877-199204001-00114  0.34
1992 Schipper J, Heyden JAMvd, Hest Av, Mos J, Poel AMvd, Olivier B. Flesinoxan: A 5-Ht1A Agonist With Anxiolytic And Antidepressant Effects In Animals. Clinical Neuropharmacology. 15. DOI: 10.1097/00002826-199202001-00218  0.349
1992 Olivier B, Mos J, Heyden JVD, Poel GVD, Tulp M, Slangen J, Jonge RD. Preclinical evidence for the anxiolytic activity of 5-HT3 receptor antagonists: A review Stress Medicine. 8: 117-136. DOI: 10.1002/Smi.2460080211  0.38
1992 Mos J, Olivier B, Tulp MTHM. Ethopharmacological studies differentiate the effects of various serotonergic compounds on aggression in rats Drug Development Research. 26: 343-360. DOI: 10.1002/Ddr.430260311  0.42
1991 Sijbesma H, Schipper J, Kloet ERd, Mos J, Aken Hv, Olivier B. Postsynaptic 5-HT1 receptors and offensive aggression in rats: a combined behavioural and autoradiographic study with eltoprazine. Pharmacology, Biochemistry and Behavior. 38: 447-458. PMID 1829232 DOI: 10.1016/0091-3057(91)90305-L  0.42
1991 Olivier B, Mos J, Miczek KA. Ethopharmacological studies of anxiolytics and aggression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 1: 97-100. PMID 1687978 DOI: 10.1016/0924-977X(91)90709-4  0.37
1991 Mos J, Logten JV, Bloetjes K, Olivier B. The effects of idazoxan and 8-OH-DPAT on sexual behaviour and associated ultrasonic vocalizations in the rat Neuroscience & Biobehavioral Reviews. 15: 505-510. PMID 1686488 DOI: 10.1016/S0149-7634(05)80140-X  0.408
1991 Olivier B, Tulp MTM, Mos J. Serotonergic receptors in anxiety and aggression; evidence from animal pharmacology Human Psychopharmacology-Clinical and Experimental. 6. DOI: 10.1002/Hup.470060511  0.385
1991 Tulp M, Olivier B, Schipper J, Poel Gvd, Mos J, Heyden JVd. Serotonin reuptake blockers: Is there preclinical evidence for their efficacy in obsessive–compulsive disorder? Human Psychopharmacology-Clinical and Experimental. 6. DOI: 10.1002/Hup.470060510  0.382
1991 Schipper J, Tulp MTM, Berkelmans B, Mos J, Heijden JAMvd, Olivier B. Preclinical pharmacology of flesinoxan: A potential anxiolytic and antidepressant drug Human Psychopharmacology-Clinical and Experimental. 6. DOI: 10.1002/Hup.470060509  0.396
1990 Ybema CE, Slangen JL, Olivier B, Mos J. Discriminative stimulus properties of flesinoxan. Pharmacology, Biochemistry and Behavior. 35: 781-784. PMID 2140607 DOI: 10.1016/0091-3057(90)90358-O  0.334
1990 Poel AMvd, Mos J, Molewijk E, Olivier B. Is Clonidine Anxiogenic in Rat Pups European Journal of Pharmacology. 183: 107-116. DOI: 10.1016/0014-2999(90)92333-E  0.352
1990 Molewijk HE, Heyden JAMVd, Olivier B. THe 5-HT1A receptor selectively mediates lower lip retraction in the rat European Journal of Pharmacology. 183: 1954-1955. DOI: 10.1016/0014-2999(90)92303-Z  0.359
1990 Hest Av, Mos J, Olivier B. Sexual behaviour in male rats: a sensitive paradigm to detect pro- and anti-sexual effects of psychoactive drugs European Journal of Pharmacology. 183: 1763-1764. DOI: 10.1016/0014-2999(90)92075-T  0.365
1990 Mos J, Olivier B, Oorschot Rv. Behavioural and neuropharmacological aspects of maternal aggression in rodents Aggressive Behavior. 16: 145-163. DOI: 10.1002/1098-2337(1990)16:3/4<145::Aid-Ab2480160303>3.0.Co;2-9  0.372
1989 Mos J, Olivier B. Quantitative and comparative analyses of pro-aggressive actions of benzodiazepines in maternal aggression of rats. Psychopharmacology. 97: 152-153. PMID 2567023 DOI: 10.1007/Bf00442238  0.335
1989 Olivier B, Mos J, van der Heyden J, Hartog J. Serotonergic modulation of social interactions in isolated male mice. Psychopharmacology. 97: 154-6. PMID 2498921 DOI: 10.1007/Bf00442239  0.383
1987 Mos J, Olivier B, Oorschot Rv. Maternal aggression towards different sized male opponents: effect of chlordiazepoxide treatment of the mothers and d-amphetamine treatment of the intruders. Pharmacology, Biochemistry and Behavior. 26: 577-584. PMID 3575374 DOI: 10.1016/0091-3057(87)90169-9  0.32
1987 Mos J, Olivier B, Lammers JHCM, Poel AMvd, Kruk MR, Zethof T. Postpartum aggression in rats does not influence threshold currents for EBS-induced aggression. Brain Research. 404: 263-266. PMID 3567571 DOI: 10.1016/0006-8993(87)91377-1  0.327
1987 Mos J, Olivier B, Poel AMvd. Modulatory actions of benzodiazepine receptor ligands on agonistic behaviour. Physiology & Behavior. 41: 265-278. PMID 2829246 DOI: 10.1016/0031-9384(87)90363-5  0.396
1986 Mos J, Olivier B. RO 15-1788 does not influence postpartum aggression in lactating female rats. Psychopharmacology. 90: 278-80. PMID 3097713 DOI: 10.1007/Bf00181259  0.379
1986 Olivier B, Mos J, Oorschot Rv. Maternal aggression in rats: lack of interaction between chlordiazepoxide and fluprazine. Psychopharmacology. 88: 40-43. PMID 2868482 DOI: 10.1007/Bf00310510  0.31
1986 Olivier B, Mos J. Serenics and aggression Stress Medicine. 2: 197-209. DOI: 10.1002/Smi.2460020305  0.307
1985 Olivier B, Mos J, Oorschot Rv. Maternal aggression in rats: effects of chlordiazepoxide and fluprazine. Psychopharmacology. 86: 68-76. PMID 3927368 DOI: 10.1007/Bf00431686  0.345
1984 Kruk MR, Laan CEVD, Mos J, Poel AMVD, Meelis W, Olivier B. Comparison of aggressive behaviour induced by electrical stimulation in the hypothalamus of male and female rats. Progress in Brain Research. 61: 303-314. PMID 6543251 DOI: 10.1016/S0079-6123(08)64443-X  0.348
1984 Mos J, Olivier B, Oorschot Rv, Dijkstra H. Different test situations for measuring offensive aggression in male rats do not result in the same wound patterns Physiology & Behavior. 32: 453-456. PMID 6540459 DOI: 10.1016/0031-9384(84)90262-2  0.306
1983 Olivier B, Olivier-Aardema R, Wiepkema PR. Effect of anterior hypothalamic and mammillary area lesions on territorial aggressive behaviour in male rats. Behavioural Brain Research. 9: 59-81. PMID 6411099 DOI: 10.1016/0166-4328(83)90014-1  0.641
1982 Poel AMvd, Olivier B, Mos J, Kruk MR, Meelis W, Aken JHMv. Anti-aggressive effect of a new phenylpiperazine compound (DU27716) on hypothalamically induced behavioural activities. Pharmacology, Biochemistry and Behavior. 17: 147-153. PMID 6889746 DOI: 10.1016/0091-3057(82)90277-5  0.326
1982 Olivier B, van Dalen D. Social behaviour in rats and mice: An ethologically based model for differentiating psychoactive drugs Aggressive Behavior. 8: 163-168. DOI: 10.1002/1098-2337(1982)8:2<163::Aid-Ab2480080219>3.0.Co;2-A  0.308
1981 Olivier B. Selective Anti-Aggressive Properties of DU 27725: Ethological Analyses of Intermale and Territorial Aggression in the Male Rat Pharmacology, Biochemistry and Behavior. 14: 61-77. PMID 6894643 DOI: 10.1016/S0091-3057(81)80012-3  0.315
1977 Olivier B. The ventromedial hypothalamus and aggressive behaviour in rats Aggressive Behavior. 3: 47-56. DOI: 10.1002/1098-2337(1977)3:1<47::Aid-Ab2480030105>3.0.Co;2-H  0.317
1974 Olivier B, Wiepkema PR. Behaviour changes in mice following electrolytic lesions in the median hypothalamus. Brain Research. 65: 521-4. PMID 4472010 DOI: 10.1016/0006-8993(74)90241-8  0.623
Show low-probability matches.